Cargando…
Anti-Inflammatory and Pro-Autophagy Effects of the Cannabinoid Receptor CB2R: Possibility of Modulation in Type 1 Diabetes
Type 1 diabetes mellitus (T1DM) is an autoimmune disease resulting from loss of insulin-secreting β-cells in islets of Langerhans. The loss of β-cells is initiated when self-tolerance to β-cell-derived contents breaks down, which leads to T cell-mediated β-cell damage and, ultimately, β-cell apoptos...
Autores principales: | Liu, Qing-Rong, Aseer, Kanikkai Raja, Yao, Qin, Zhong, Xiaoming, Ghosh, Paritosh, O’Connell, Jennifer F., Egan, Josephine M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804091/ https://www.ncbi.nlm.nih.gov/pubmed/35115945 http://dx.doi.org/10.3389/fphar.2021.809965 |
Ejemplares similares
-
An Autonomous Cannabinoid System in Islets of Langerhans
por: Aseer, Kanikkai Raja, et al.
Publicado: (2021) -
Hepatocyte cannabinoid 1 receptor nullification alleviates toxin-induced liver damage via NF-κB signaling
por: Kim, Yoo, et al.
Publicado: (2020) -
Cannabigerol Action at Cannabinoid CB(1) and CB(2) Receptors and at CB(1)–CB(2) Heteroreceptor Complexes
por: Navarro, Gemma, et al.
Publicado: (2018) -
Voltage dependence of the cannabinoid CB1 receptor
por: Goldberger, Esty, et al.
Publicado: (2022) -
Editorial: Therapeutic potential of the cannabinoid CB2 receptor
por: Smoum, Reem, et al.
Publicado: (2022)